313 related articles for article (PubMed ID: 25506897)
21. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
22. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
23. FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.
Gong AH; Wei P; Zhang S; Yao J; Yuan Y; Zhou AD; Lang FF; Heimberger AB; Rao G; Huang S
Cancer Res; 2015 Jun; 75(11):2337-48. PubMed ID: 25832656
[TBL] [Abstract][Full Text] [Related]
24. Autophagy induction impairs Wnt/β-catenin signalling through β-catenin relocalisation in glioblastoma cells.
Colella B; Faienza F; Carinci M; D'Alessandro G; Catalano M; Santoro A; Cecconi F; Limatola C; Di Bartolomeo S
Cell Signal; 2019 Jan; 53():357-364. PubMed ID: 30442596
[TBL] [Abstract][Full Text] [Related]
25. Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer.
Zhang J; Niu Y; Huang C
Recent Pat Anticancer Drug Discov; 2017; 12(3):247-259. PubMed ID: 28440206
[TBL] [Abstract][Full Text] [Related]
26. The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation.
Iser IC; Pereira MB; Lenz G; Wink MR
Med Res Rev; 2017 Mar; 37(2):271-313. PubMed ID: 27617697
[TBL] [Abstract][Full Text] [Related]
27. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
[TBL] [Abstract][Full Text] [Related]
28. FoxM1 promotes glioma cells progression by up-regulating Anxa1 expression.
Cheng SX; Tu Y; Zhang S
PLoS One; 2013; 8(8):e72376. PubMed ID: 23991102
[TBL] [Abstract][Full Text] [Related]
29. miR‑96 inhibits EMT by targeting AEG‑1 in glioblastoma cancer cells.
Feng S; Yao J; Zhang Z; Zhang Y; Zhang Z; Liu J; Tan W; Sun C; Chen L; Yu X
Mol Med Rep; 2018 Feb; 17(2):2964-2972. PubMed ID: 29257267
[TBL] [Abstract][Full Text] [Related]
30. PL-hMSC and CH-hMSC derived soluble factors inhibit proliferation but improve hGBM cell migration by activating TGF-β and inhibiting Wnt signaling.
Uthanaphun T; Manochantr S; Tantrawatpan C; Tantikanlayaporn D; Kheolamai P
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38687607
[TBL] [Abstract][Full Text] [Related]
31. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
[TBL] [Abstract][Full Text] [Related]
32. POLE2 facilitates the malignant phenotypes of glioblastoma through promoting AURKA-mediated stabilization of FOXM1.
Zhang P; Chen X; Zhang L; Cao D; Chen Y; Guo Z; Chen J
Cell Death Dis; 2022 Jan; 13(1):61. PubMed ID: 35039475
[TBL] [Abstract][Full Text] [Related]
33. The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma.
Ma Q; Liu Y; Shang L; Yu J; Qu Q
Oncol Rep; 2017 Dec; 38(6):3367-3375. PubMed ID: 29039578
[TBL] [Abstract][Full Text] [Related]
34. ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.
Chong YK; Sandanaraj E; Koh LW; Thangaveloo M; Tan MS; Koh GR; Toh TB; Lim GG; Holbrook JD; Kon OL; Nadarajah M; Ng I; Ng WH; Tan NS; Lim KL; Tang C; Ang BT
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26547933
[TBL] [Abstract][Full Text] [Related]
35. Role of Klotho Protein in Tumor Genesis, Cancer Progression, and Prognosis in Patients with High-Grade Glioma.
Peshes-Yeloz N; Ungar L; Wohl A; Jacoby E; Fisher T; Leitner M; Nass D; Rubinek T; Wolf I; Cohen ZR
World Neurosurg; 2019 Oct; 130():e324-e332. PubMed ID: 31228703
[TBL] [Abstract][Full Text] [Related]
36. Integrin α3 Mediates Stemness and Invasion of Glioblastoma by Regulating POU3F2.
Yao J; Wang L
Curr Protein Pept Sci; 2023; 24(3):247-256. PubMed ID: 36843258
[TBL] [Abstract][Full Text] [Related]
37. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
Cheng P; Ma Y; Gao Z; Duan L
Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
39. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
[TBL] [Abstract][Full Text] [Related]
40. DRR1 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via regulating AKT activation.
Ma YS; Wu ZJ; Bai RZ; Dong H; Xie BX; Wu XH; Hang XS; Liu AN; Jiang XH; Wang GR; Jiang JJ; Xu WH; Chen XP; Tan GH; Fu D; Liu JB; Liu Q
Cancer Lett; 2018 Jun; 423():86-94. PubMed ID: 29548818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
